Paul B. Manning - Insider Trading & Ownership

Location: 200 Garrett Street Suite S, Charlottesville, VA
Summary: The estimated net worth of Paul B. Manning is at least $142M dollars as of November 25, 2025. Paul B. Manning is the Director of Liquidia Corp and owns shares of Liquidia Corp (LQDA) stock worth about $72.9M. Paul B. Manning is the Director, 10%+ Owner of Verrica Pharmaceuticals Inc. and owns shares of Verrica Pharmaceuticals Inc. (VRCA) stock worth about $32.2M. Paul B. Manning is the Director of Candel Therapeutics, Inc. and owns shares of Candel Therapeutics, Inc. (CADL) stock worth about $26.7M. Paul B. Manning is the 10%+ Owner of Taysha Gene Therapies, Inc. and owns shares of Taysha Gene Therapies, Inc. (TSHA) stock worth about $7.81M. Paul B. Manning is the 10%+ Owner of Acumen Pharmaceuticals, Inc. and owns shares of Acumen Pharmaceuticals, Inc. (ABOS) stock worth about $2.28M.
Signature: /s/ Mark Ballantyne, Attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Paul B. Manning files a new Insider Trading report.

Ownership of Paul B. Manning

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
LQDA	Liquidia Corp	Director	$72.9M	-$19M	-20.6%	Aug 28, 2025
VRCA	Verrica Pharmaceuticals Inc.	Director, 10%+ Owner	$32.2M	+$17.5M	+119%	Nov 25, 2025
CADL	Candel Therapeutics, Inc.	Director	$26.7M	+$7.5M	+39.1%	Jun 25, 2025
TSHA	Taysha Gene Therapies, Inc.	10%+ Owner	$7.81M	+$2.06M	+35.9%	May 30, 2025
ABOS	Acumen Pharmaceuticals, Inc.	10%+ Owner	$2.28M			Jul 6, 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.